We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+24.29%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$782M
AUM Growth
+$121M
Cap. Flow
+$72.8K
Cap. Flow %
0.01%
Top 10 Hldgs %
54.41%
Holding
77
New
6
Increased
14
Reduced
30
Closed
8

Top Buys

Rank Stock Value
1
KRMD icon
KORU Medical Systems
KRMD
+$35.2M
2
TNDM icon
Tandem Diabetes Care
TNDM
+$8.16M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$6.75M
4
VTRS icon
Viatris
VTRS
+$6.41M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.13M

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$10.8M
2
AMRN
Amarin Corp
AMRN
+$8.75M
3
BMY icon
Bristol-Myers Squibb
BMY
+$6.04M
4
TAK icon
Takeda Pharmaceutical
TAK
+$4.87M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$4.82M

Sector Composition

Rank Sector Weight
1 Healthcare 72.61%
2 Communication Services 8.79%
3 Industrials 1.3%
4 Energy 0.94%
5 Financials 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MODN
1
DELISTED
MODEL N, INC.
MODN
$68.8M 8.79%
1,960,725
-9,319
-0.5% -$284K
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$67.7M 8.66%
4,081,055
+361,764
+10% +$5.87M
KRMD icon
3
KORU Medical Systems
KRMD
$189M
$47.1M 6.02%
+7,218,014
New +$35.2M
NEO icon
4
NeoGenomics
NEO
$1.96B
$39.1M 5%
1,336,949
+17,203
+1% +$410K
MYOK
5
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$38.8M 4.96%
531,884
-2,060
-0.4% -$125K
OMCL icon
6
Omnicell
OMCL
$1.61B
$37.1M 4.74%
453,504
-2,233
-0.5% -$171K
ATRC icon
7
AtriCure
ATRC
$1.92B
$36.2M 4.62%
1,112,698
+6,989
+0.6% +$199K
INSM icon
8
Insmed
INSM
$21.4B
$30.9M 3.95%
1,293,548
-1,195
-0.1% -$24.3K
HALO icon
9
Halozyme
HALO
$9.79B
$30.2M 3.85%
1,700,782
+18,037
+1% +$312K
XENT
10
DELISTED
Intersect ENT, Inc
XENT
$29.9M 3.82%
1,199,169
-16,953
-1% -$344K
IMMU
11
DELISTED
Immunomedics Inc
IMMU
$26.3M 3.37%
1,245,243
-5,293
-0.4% -$93.4K
HRTX icon
12
Heron Therapeutics
HRTX
$93.9M
$25.4M 3.25%
1,081,159
-9,951
-0.9% -$220K
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$24.1M 3.08%
1,008,957
+244,861
+32% +$6.75M
SPNE
14
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$21.9M 2.8%
1,826,404
-26,152
-1% -$319K
CDXS icon
15
Codexis
CDXS
$151M
$19M 2.42%
1,186,113
-12,339
-1% -$183K
TEVA icon
16
Teva Pharmaceuticals
TEVA
$40.8B
$16.2M 2.07%
1,656,171
+686,941
+71% +$6.13M
TNDM icon
17
Tandem Diabetes Care
TNDM
$1.34B
$16M 2.05%
268,574
+132,246
+97% +$8.16M
SIBN icon
18
SI-BONE Inc
SIBN
$788M
$14.7M 1.88%
685,131
+39,149
+6% +$702K
IONS icon
19
Ionis Pharmaceuticals
IONS
$8.6B
$14.7M 1.88%
243,691
-80,958
-25% -$4.82M
VAPO
20
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$13.9M 1.78%
143,376
+15,409
+12% +$1.3M
XNCR icon
21
Xencor
XNCR
$1.5B
$11.5M 1.47%
333,855
-1,589
-0.5% -$58K
VCYT icon
22
Veracyte
VCYT
$3.7B
$11.4M 1.46%
409,077
-1,848
-0.4% -$47.8K
VTRS icon
23
Viatris
VTRS
$20.4B
$10.7M 1.37%
532,783
+344,493
+183% +$6.41M
TRHC
24
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$10.2M 1.3%
209,689
+14,342
+7% +$672K
AMRN
25
Amarin Corp
AMRN
$299M
$9.83M 1.26%
22,914
-23,028
-50% -$8.75M
1
2 3 4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, First Light Asset Management held 77 positions worth $782M, up 18% from $662M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

First Light Asset Management's Q4 2019 filing shows 6 new, 14 increased, 30 reduced and 8 closed positions. Its largest new stake was KORU Medical Systems: 7,218,014 shares worth $47.1M. The largest sale was Agios Pharmaceuticals, an estimated $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 68% a quarter earlier, followed by Communication Services and Industrials.

  • First Light Asset Management's largest Q4 2019 buy was KORU Medical Systems: 7,218,014 shares worth $47.1M.
  • First Light Asset Management added most to Tandem Diabetes Care in Q4 2019, an estimated $8.16M increase.
  • First Light Asset Management's biggest Q4 2019 reduction was Amarin Corp, cutting an estimated $8.75M.
  • First Light Asset Management fully exited Agios Pharmaceuticals in Q4 2019, selling an estimated $10.8M.
  • First Light Asset Management's ten largest holdings make up 54% of its $782M portfolio in Q4 2019.
  • First Light Asset Management opened 6 new positions and closed 8 in Q4 2019.
  • First Light Asset Management's portfolio value rose 18% quarter-over-quarter to $782M.

Based on First Light Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.